Research

A recent study explored cannabis use and age-related cognitive decline in men, taking into account first use of cannabis and usage frequency.

A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.

Here, Scott Mazza, Founder of Vitality CBD, provides an overview on the potential benefits of minor cannabinoids including cannabinol (CBN) and cannabingerol (CBG).

In this segment of the cultivation education series, Adam Jacques and Zacariah L. Hildenbrand delve into croptober and the complexities that arise with outdoor, hybrid, and indoor cannabis cultivation.

The second part of this column will take a look at specific examples in the public domain of elemental contamination of cannabis consumer products, which shows that other elements are worthy of consideration and should be a part of the regulatory framework.

The five-year study will be supported by a $2.2 million grant from the National Institute of Drug Abuse.

The researchers point out that it is important for clinicians to ask about CBD use to better advise patients and prevent potential drug interactions.

Researchers shared their latest research on the fungus that is a threat to seeds and crops across the nation.

Overall, the survey revealed that people with chronic pain supported policies expanding medical cannabis access more than physicians.

The studies highlight how changes in environment can alter cannabis during drying and curing.

Researchers analyzed studies from the past two decades on the impact of cannabinoids on neuropathic pain and potential benefits.

The study surveyed cannabis patients across the country on their use and perceptions of cannabis use during cancer treatment.

Avicanna released information on a new study through MyMedi.ca which will look into the use of medical cannabis for various health ailments such as pain, anxiety, epilepsy, sleep, and depression.

Panelists discussed the impacts of cannabis as a schedule 3 substance on research, legislation, patients, and more.

The study found improvement in symptom relief with participants who used the suppositories, compared to the treatment-as-usual group.

A Tilray-funded case series found that cannabinoid treatment provided pain relief and improved other symptoms.

Products containing Delta-8 THC may be leading to an increase in calls to poison control centers, according to a recent study.

A recently published white paper delves into data on market and consumer trends for pre rolls.

A recent study targeting mild to moderate anxiety disorders showed that oral CBD can be a safe, effective treatment option.

This study shares how polysorbate 80 can be used in homogenization of cannabis concentrates to first determine if this additive aids in the extraction of the cannabis extract matrix and then testing to see how well target organisms survive in the extraction environment.

Researchers sought to provide community-based evidence in the co-use of opioids and cannabis among people who inject drugs.

A new study demonstrates the neuroprotective properties of the supplement N-Acetylcysteine against effects of cannabis exposure in adolescence.

A recently published study found that patients using medical marijuana reported a significant increase in subjective improvements of gastrointestinal (GI) symptom severity, compared to not using medical marijuana.

This month’s Healer webinar provided a deep dive into several studies on cannabis for various conditions.

This presentation provided a comprehensive overview of cannabigerol (CBG), highlighting two studies on its effects on anxiety, stress, and pain.

A recently published study examined data on thousands of pregnancies, maternal health outcomes, and cannabis use.

This month’s webinar discussed studies conducted on cannabis and psychedelics for various conditions including anxiety and autism spectrum disorder.

Check out some of our most popular content from the first six months of the year 2024!

In continuation of our cultivation education series, Adam Jacques and Zacariah L. Hildenbrand, get to the root of the issue of experiencing an HLVd infestation and if anything can be done to salvage your crops.

The first part of this column examines the fractured nature of state-based regulations and compares it with the federal limits for pharmaceutical products and dietary supplements.